BURKHOLDERIA CEPACIA COMPLEX IN PERSONAL CARE PRODUCTS 147 (22) K. Ve r mis, T. Coenye, J. J. LiPuma, E. Mahenthiralingam, H. J. Nelis, and P. Vandamme, Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int. J. Syst. Evol. Micro- biol., 54, 689–691 (2004). (23) P. Va n damme, B. Holmes, T. Coenye, J. Goris, E. Mahenthiralingam, J. J. LiPuma, and J. R. Govan, Burkholderia cenocepacia sp. nov.-a new twist to an old story, Res. Microbiol., 154, 91–96 (2003). (24) P. Va n damme, D. Henry, T. Coenye, S. Nzula, M. Vancanneyt, J. J. LiPuma, D. P. Speert, J. R. W. Govan, and E. Mahenthiralingam, Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two addi- tional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools, FEMS Immunol. Med. Microbiol., 33, 143–149 (2002). (25) E. Va n laere, A. Baldwin, D. Gevers, D. Henry, E. De Brandt, J. J. LiPuma, E. Mahenthiralingam, D. P. Speert, C. Dowson, P. Vandamme, and K. Taxon, A complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int. J. Syst. Evol. Microbiol., 59, 102–111 (2009). (26) T. Co e nye, E. Mahenthiralingam, D. Henry, J. J. LiPuma, S. Laevens, M. Gillis, D. P. Speert, and P. Vandamme, Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex includ- ing biocontrol and cystic fi brosis-related isolates, Int. J. Syst. Evol. Microbiol., 51, 1481–1490 (2001). (27) P. Va n damme, E. Mahenthiralingam, B. Holmes, T. Coenye, B. Hoste, P. De Vos, D. Henry, and D. P. Speert, Identifi cation and population structure of Burkholderia stabilis sp. nov.(formerly Burkholderia cepacia Genomovar IV), J. Clin. Microbiol., 38, 1042–1047 (2000). (28) P. Va n damme, B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. W. Govan, Occurrence of multiple genomovars of Burkholderia cepacia in cystic fi brosis patients and proposal of Burkholderia multivorans sp. nov, Int. J. Syst. Evol. Microbiol., 47, 1188–1200 (1997). (29) M. Gi l lis, T. Van, R. Bardin, M. Goor, P. Hebbar, A. Willems, P. Segers, K. Kersters, T. Heulin, and M. P. Fernandez, Polyphasic taxonomy in the genus Burkholderia leading to an emended description of the genus and proposition of Burkholderia vietnamiensis sp. nov. for N2-fi xing isolates from rice in Vietnam, Int. J. Syst. Evol. Microbiol., 45, 274–289 (1995). (30) W. H. Burkholder, Sour skin, a bacterial rot of onion bulbs, Phytopathology, 40, 115–117 (1950). (31) S. Sut ton and L. Jimenez, Microbiology-A review of reported recalls involving microbiological control 2004–2011 with emphasis on FDA considerations of “objectionable organisms”, Am. Pharmaceut. Rev., 15, 42 (2012). (32) Y. C . Chien, C. H. Liao, W. H. Sheng, J. Y. Chien, Y. T. Huang, C. J. Yu, and P. R. Hsueh, Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial suscep- tibility of the isolates in a medical centre in Taiwan. Int. J. Antimicrob. Agents, 51, 357–364 (2018). (33) G. W. Payne, P. Vandamme, S. H. Morgan, J. J. Lipuma, T. Coenye, Weightman A. J., T. Hefi n-Jones, and E. Mahenthiralingam, Development of a recA gene-based identifi cation approach for the entire burkholderia genus, Appl. Environ. Microbiol., 71, 3917 (2005). (34) A. B a l dwin, E. Mahenthiralingam, K. M. Thickett, D. Honeybourne, M. C. Maiden, J. R. Govan, D. P. Speert, J. J. LiPuma, P. Vandamme, and C. G. Dowson, Multilocus sequence typing scheme that pro- vides both species and strain differentiation for the Burkholderia cepacia complex, J. Clin. Microbiol., 43, 4665–4673 (2005). (35) T. Sp i lker, A. Baldwin, A. Bumford, C. G. Dowson, E. Mahenthiralingam, and J. J. Lipuma, Expanded multilocus sequence typing for Burkholderia species, J. Clin. Microbiol., 47, 2607–2610 (2009). (36) H. Ro s e, A. Baldwin, C. G. Dowson, and E. Mahenthiralingam, Biocide susceptibility of the Burkhold- eria cepacia complex, J. Antimicrob. Chemother., 63, 502–510 (2009). (37) L. Fe r nández, E. B. M. Breidenstein, and R. E. W. Hancock, Creeping baselines and adaptive resistance to antibiotics, Drug Resist. Updates, 14, 1–21 (2011). (38) E. Mah e nthiralingam, J. Bischof, S. K. Byrne, C. Radomski, J. E. Davies, Y. Av-Gay, and P. Vandamme, DNA-based diagnostic approaches for identifi cation of Burkholderia cepacia complex, Burkholderia vietna- miensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III, J. Clin. Microbiol., 38, 3165–3173 (2000). (39) K. A. J olley and M. C. Maiden, BIGSdb: scalable analysis of bacterial genome variation at the popula- tion level, BMC Bioinf., 11, 595 (2010). (40) M. Pér i amé, J. M. Pagès, and A. Davin-Regli, Enterobacter gergoviae adaptation to preservatives com- monly used in cosmetic industry, Int. J. Cosmet. Sci., 36(4), 386–395 (2014). (41) G . Y. Lars en, T. L. Stull, and J. L. Burns, Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fi brosis, J. Clin. Microbiol., 31, 788–792 (1993).
JOURNAL OF COSMETIC SCIENCE 148 (42) T. Coenye , P. Vandamme, J. R. Govan, and J. J. LiPuma, Taxonomy and identifi cation of the Burkhold- eria cepacia complex, J. Clin. Microbiol., 39, 3427–3436 (2001). (43) G. Zhou, Q . Shi, Y. Ouyang, and Y. B. Chen, Involvement of outer membrane proteins and peroxide- sensor genes in Burkholderia cepacia resistance to isothiazolone, World J. Microbiol. Biotechnol., 30, 1251– 1260 (2014). (44) K. A. Rho d es and H. P. Schweizer, Antibiotic resistance in Burkholderia species, Drug Resist. Updates, 28, 82–90 (2016). (45) V. Gautam , P. P. Patil, S. Kumar, S. Midha, M. Kaur, S. Kaur, M. Singh, S. Mali, J. Shastri, A. Arora, P. Ray, and P. B. Patil, Multilocus sequence analysis reveals high genetic diversity in clinical isolates of Burkholderia cepacia complex from India, Sci. Rep., 6, 35769 (2016). (46) A. Balwin , A. Mahenthiralingam, P. Drevinek, P. Vandamme, J. Govan, and D. Waine, Environmental Burkholderia cepacia complex isolates in human infections, Emerg. Infect. Dis., 13, 458–461 (2007).
Previous Page Next Page